🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

HOTCHKIS & WILEY’s ANIP Holdings & Trades

First Buy
Q3 2024
Duration Held
9 Quarters
Largest Add
Q3 2026
+119,597 Shares
Current Position
204,017 Shares
$14.82 M Value

HOTCHKIS & WILEY's ANIP Position Overview

HOTCHKIS & WILEY (via Hotchkis & Wiley Capital Management LLC) currently holds 204,017 shares of ANI Pharmaceuticals, Inc. (ANIP) worth $14.82 M, representing 0.04% of the portfolio. First purchased in 2024-Q3, this medium-term investment has been held for 9 quarters.

Based on 13F filings, HOTCHKIS & WILEY has maintained a strategic position in ANIP, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2026, adding 119,597 shares. Largest reduction occurred in Q2 2025, reducing 21,990 shares.

Analysis based on 13F filings available since 2013 Q2

HOTCHKIS & WILEY's ANI Pharmaceuticals (ANIP) Holding Value Over Time

Track share changes against reported price movement

Quarterly ANI Pharmaceuticals (ANIP) Trades by HOTCHKIS & WILEY

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +119,597 Add 141.67% 204,017 $72.65
Q2 2026 +1,370 Add 1.65% 84,420 $82.78
Q1 2026 +8,270 Add 11.06% 83,050 $76.90
Q4 2025 +320 Add 0.43% 74,780 $78.94
Q3 2025 -12,150 Reduce 14.03% 74,460 $91.60
Q2 2025 -21,990 Reduce 20.25% 86,610 $65.25
Q1 2025 +51,420 Add 89.93% 108,600 $66.95
Q4 2024 +5,100 Add 9.79% 57,180 $55.28
Q3 2024 +52,080 New Buy 52,080 $59.66

HOTCHKIS & WILEY's ANI Pharmaceuticals Investment FAQs

HOTCHKIS & WILEY first purchased ANI Pharmaceuticals, Inc. (ANIP) in Q3 2024, acquiring 52,080 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

HOTCHKIS & WILEY has held ANI Pharmaceuticals, Inc. (ANIP) for 9 quarters since Q3 2024.

HOTCHKIS & WILEY's largest addition to ANI Pharmaceuticals, Inc. (ANIP) was in Q3 2026, adding 204,017 shares worth $14.82 M.

According to the latest 13F filing for Q3 2026, HOTCHKIS & WILEY's firm, Hotchkis & Wiley Capital Management LLC, owns 204,017 shares of ANI Pharmaceuticals, Inc. (ANIP), valued at approximately $14.82 M.

As of the Q3 2026 filing, ANI Pharmaceuticals, Inc. (ANIP) represents approximately 0.04% of HOTCHKIS & WILEY's publicly disclosed stock portfolio, making it one of their key holdings.

HOTCHKIS & WILEY's peak holding in ANI Pharmaceuticals, Inc. (ANIP) was 204,017 shares, as reported at the end of Q3 2026.